JP Morgan Maintains Neutral on Aveanna Healthcare Hldgs, Raises Price Target to $15
JP Morgan analyst Benjamin Rossi maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Neutral and raises the price target from $8 to $15.
Stocks · News reference
Cramer favored ET, PANW and CRWD over SentinelOne, advised waiting on Corning, called GEMI speculative, and supported holding Aveanna.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
JP Morgan analyst Benjamin Rossi maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Neutral and raises the price target from $8 to $15.
Inspire Medical, Cybin and Aveanna show overbought RSI readings above 70, signaling potential momentum warnings for healthcare investors.
Cybersecurity ETFs are sliding as CrowdStrike, Palo Alto Networks and Okta face valuation concerns after a rally. Here’s what it means for the AI-driven trade.
The Fed hiked for the first time since 2023; the 10-year yield touched 5.04%, and record diesel prices hit truckers and automakers.
B of A Securities analyst Tal Liani maintains CrowdStrike Holdings (NASDAQ:CRWD) with a Neutral and raises the price target from $230 to $260.